Your LifeMD-affiliated provider will review your information and work with you to create a treatment plan, if appropriate, that can help you reach your target weight
More recently, dual GIP/GLP-1 RAs, such as tirzepatide, as well as emerging dual and triple incretin-based therapies, have demonstrated substantial efficacy in both glycaemic and weight control
The body still needs adequate fuel to support muscle repair, connective tissue recovery, glycogen replenishment, hormone function, tissue healing, and workout adaptation even if hunger signals are muted
a 6% decrease in low-density lipoprotein and total cholesterol concentrations was previously observed during 2-week run-in in a trial of orlistat versus placebo treatment